PubMed

Pharmacokinetics and Safety of Sunitinib Malate in Subjects With Impaired Renal Function.

Khosravan R, Toh M, Garrett M, La Fargue J, Ni G, Marbury TC, Swan SK, Lunde NM, Bello CL.

J Clin Pharmacol. 2009 Sep 24. [Epub ahead of print]PMID: 19779038 [PubMed - as supplied by publisher]Related articles

Multiple-dose pharmacokinetics of peginterferon alfa-2b in patients with renal insufficiency.

Gupta SK, Swan SK, Marbury T, Smith W, Schwartz S, Kolz K, Cutler DL.

Br J Clin Pharmacol. 2007 Dec;64(6):726-32. Epub 2007 Jun 6.PMID: 17555463 [PubMed - indexed for MEDLINE]Related articlesFree article

Pharmacokinetics and safety of ebastine in healthy subjects and patients with renal impairment.

Noveck RJ, Preston RA, Swan SK.

Clin Pharmacokinet. 2007;46(6):525-34.PMID: 17518511 [PubMed - indexed for MEDLINE]Related articles

Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor.

Bergman AJ, Cote J, Yi B, Marbury T, Swan SK, Smith W, Gottesdiener K, Wagner J, Herman GA.

Diabetes Care. 2007 Jul;30(7):1862-4. Epub 2007 Apr 27. No abstract available. PMID: 17468348 [PubMed - indexed for MEDLINE]Related articlesFree article

Pharmacokinetics of maribavir, a novel oral anticytomegalovirus agent, in subjects with varying degrees of renal impairment.

Swan SK, Smith WB, Marbury TC, Schumacher M, Dougherty C, Mico BA, Villano SA.

J Clin Pharmacol. 2007 Feb;47(2):209-17.PMID: 17244772 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetic profile of rizatriptan 10-mg tablet and 10-mg orally disintegrating tablet administered with or without water in healthy subjects: an open-label, randomized, single-dose, 3-period crossover study.

Swan SK, Alcorn H Jr, Rodgers A, Hustad CM, Ramsey KE, Woll S, Skobieranda F.

J Clin Pharmacol. 2006 Feb;46(2):172-8.PMID: 16432269 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics of micafungin in healthy volunteers, volunteers with moderate liver disease, and volunteers with renal dysfunction.

Hebert MF, Smith HE, Marbury TC, Swan SK, Smith WB, Townsend RW, Buell D, Keirns J, Bekersky I.

J Clin Pharmacol. 2005 Oct;45(10):1145-52.PMID: 16172179 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics, safety, and tolerability of intramuscular ziprasidone in healthy volunteers.

Miceli JJ, Wilner KD, Swan SK, Tensfeldt TG.

J Clin Pharmacol. 2005 Jun;45(6):620-30.PMID: 15901743 [PubMed - indexed for MEDLINE]Related articles

Effect of ketoconazole on the pharmacokinetics and safety of telithromycin and clarithromycin in older subjects with renal impairment.

Shi J, Chapel S, Montay G, Hardy P, Barrett JS, Sica D, Swan SK, Noveck R, Leroy B, Bhargava VO.

Int J Clin Pharmacol Ther. 2005 Mar;43(3):123-33.PMID: 15792396 [PubMed - indexed for MEDLINE]Related articles

A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease.

Murray PT, Reddy BV, Grossman EJ, Hammes MS, Trevino S, Ferrell J, Tang I, Hursting MJ, Shamp TR, Swan SK.

Kidney Int. 2004 Dec;66(6):2446-53.PMID: 15569338 [PubMed - indexed for MEDLINE]Related articles

The pharmacokinetics and hemodynamics of sildenafil citrate in male hemodialysis patients.

Grossman EB, Swan SK, Muirhead GJ, Gaffney M, Chung M, DeRiesthal H, Chow D, Raij L.

Kidney Int. 2004 Jul;66(1):367-74.PMID: 15200445 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics and safety of the ketolide telithromycin in patients with renal impairment.

Shi J, Montay G, Chapel S, Hardy P, Barrett JS, Sack M, Marbury T, Swan SK, Vargas R, Leclerc V, Leroy B, Bhargava VO.

J Clin Pharmacol. 2004 Mar;44(3):234-44.PMID: 14973302 [PubMed - indexed for MEDLINE]Related articles

Tegaserod pharmacokinetics are similar in patients with severe renal insufficiency and in healthy subjects.

Swan SK, Zhou H, Horowitz A, Alladina L, Hubert M, Appel-Dingemanse S, Osborne S, Lambrecht L, McLeod JF.

J Clin Pharmacol. 2003 Apr;43(4):359-64.PMID: 12723456 [PubMed - indexed for MEDLINE]Related articles

Does uremia protect against the demyelination associated with correction of hyponatremia during hemodialysis? A case report and literature review.

Oo TN, Smith CL, Swan SK.

Semin Dial. 2003 Jan-Feb;16(1):68-71. Review.PMID: 12535304 [PubMed - indexed for MEDLINE]Related articles

Single-dose pharmacokinetics and safety of pegylated interferon-alpha2b in patients with chronic renal dysfunction.

Gupta SK, Pittenger AL, Swan SK, Marbury TC, Tobillo E, Batra V, Sack M, Glue P, Jacobs S, Affrime M.

J Clin Pharmacol. 2002 Oct;42(10):1109-15.PMID: 12362925 [PubMed - indexed for MEDLINE]Related articles

Intravenous and subcutaneous weight-based dosing of the low molecular weight heparin tinzaparin (Innohep) in end-stage renal disease patients undergoing chronic hemodialysis.

Hainer JW, Sherrard DJ, Swan SK, Barrett JS, Assaid CA, Fossler MJ, Cox DS, Williams RM, Pittenger AL, Stephenson CA, Hua TA.

Am J Kidney Dis. 2002 Sep;40(3):531-8.PMID: 12200805 [PubMed - indexed for MEDLINE]Related articles

Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients.

Nissenson AR, Swan SK, Lindberg JS, Soroka SD, Beatey R, Wang C, Picarello N, McDermott-Vitak A, Maroni BJ.

Am J Kidney Dis. 2002 Jul;40(1):110-8.PMID: 12087568 [PubMed - indexed for MEDLINE]Related articles

Cyclooxygenase-2 and atherosclerosis: friend or foe?

Massy ZA, Swan SK.

Nephrol Dial Transplant. 2001 Dec;16(12):2286-9. Review. No abstract available. PMID: 11733615 [PubMed - indexed for MEDLINE]Related articlesFree article

Pharmacokinetics of pilocarpine in subjects with varying degrees of renal function.

St Peter JV, Lambrecht LJ, Gunderson BW, Andersen SA, Gallagher SC, Swan SK.

J Clin Pharmacol. 2000 Dec;40(12 Pt 2):1470-5.PMID: 11185668 [PubMed - indexed for MEDLINE]Related articles

Safety of intravenous gadolinium (Gd-BOPTA) infusion in patients with renal insufficiency.

Townsend RR, Cohen DL, Katholi R, Swan SK, Davies BE, Bensel K, Lambrecht L, Parker J.

Am J Kidney Dis. 2000 Dec;36(6):1207-12.PMID: 11096046 [PubMed - indexed for MEDLINE]Related articles

Comparison of anticoagulant effects and safety of argatroban and heparin in healthy subjects.

Swan SK, St Peter JV, Lambrecht LJ, Hursting MJ.

Pharmacotherapy. 2000 Jul;20(7):756-70.PMID: 10907966 [PubMed - indexed for MEDLINE]Related articles

Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.

Swan SK, Rudy DW, Lasseter KC, Ryan CF, Buechel KL, Lambrecht LJ, Pinto MB, Dilzer SC, Obrda O, Sundblad KJ, Gumbs CP, Ebel DL, Quan H, Larson PJ, Schwartz JI, Musliner TA, Gertz BJ, Brater DC, Yao SL.

Ann Intern Med. 2000 Jul 4;133(1):1-9.PMID: 10877734 [PubMed - indexed for MEDLINE]Related articlesFree article

The generation of non-dextran intravenous iron: is iron dextran obsolete?

Lewis MJ, Swan SK.

Semin Dial. 2000 Jan-Feb;13(1):9-10. Review. No abstract available. PMID: 10740666 [PubMed - indexed for MEDLINE]Related articles

The pharmacokinetics and pharmacodynamics of argatroban: effects of age, gender, and hepatic or renal dysfunction.

Swan SK, Hursting MJ.

Pharmacotherapy. 2000 Mar;20(3):318-29.PMID: 10730687 [PubMed - indexed for MEDLINE]Related articles

Disposition of recombinant human interleukin-10 in subjects with various degrees of renal function.

Andersen SR, Lambrecht LJ, Swan SK, Cutler DL, Radwanski E, Affrime MB, Garaud JJ.

J Clin Pharmacol. 1999 Oct;39(10):1015-20.PMID: 10516935 [PubMed - indexed for MEDLINE]Related articles

The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects.

Mathur VS, Swan SK, Lambrecht LJ, Anjum S, Fellmann J, McGuire D, Epstein M, Luther RR.

Crit Care Med. 1999 Sep;27(9):1832-7.PMID: 10507606 [PubMed - indexed for MEDLINE]Related articles

Review article: the pharmacokinetics of rabeprazole in health and disease.

Swan SK, Hoyumpa AM, Merritt GJ.

Aliment Pharmacol Ther. 1999 Aug;13 Suppl 3:11-7. Review.PMID: 10491724 [PubMed - indexed for MEDLINE]Related articlesFree article

Rabeprazole: pharmacokinetics and tolerability in patients with stable, end-stage renal failure.

Keane WF, Swan SK, Grimes I, Humphries TJ.

J Clin Pharmacol. 1999 Sep;39(9):927-33.PMID: 10471983 [PubMed - indexed for MEDLINE]Related articles

Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment.

Swan SK, Lambrecht LJ, Townsend R, Davies BE, McCloud S, Parker JR, Bensel K, LaFrance ND.

Invest Radiol. 1999 Jul;34(7):443-8.PMID: 10399633 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics, safety, and tolerability of gadoversetamide injection (OptiMARK) in subjects with central nervous system or liver pathology and varying degrees of renal function.

Swan SK, Baker JF, Free R, Tucker RM, Barron B, Barr R, Seltzer S, Gazelle GS, Maravilla KR, Barr W, Stevens GR, Lambrecht LJ, Pierro JA.

J Magn Reson Imaging. 1999 Feb;9(2):317-21.PMID: 10077031 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics of flutamide in patients with renal insufficiency.

Anjum S, Swan SK, Lambrecht LJ, Radwanski E, Cutler DL, Affrime MB, Halstenson CE.

Br J Clin Pharmacol. 1999 Jan;47(1):43-7.PMID: 10073738 [PubMed - indexed for MEDLINE]Related articlesFree article

The pharmacokinetics of a single oral dose of mycophenolate mofetil in patients with varying degrees of renal function.

Johnson HJ, Swan SK, Heim-Duthoy KL, Nicholls AJ, Tsina I, Tarnowski T.

Clin Pharmacol Ther. 1998 May;63(5):512-8.PMID: 9630824 [PubMed - indexed for MEDLINE]Related articles

Predictive performance of renal function estimate equations in renal allografts.

Goerdt PJ, Heim-Duthoy KL, Macres M, Swan SK.

Br J Clin Pharmacol. 1997 Sep;44(3):261-5.PMID: 9296320 [PubMed - indexed for MEDLINE]Related articlesFree article

The search continues--an ideal marker of GFR.

Swan SK.

Clin Chem. 1997 Jun;43(6 Pt 1):913-4. No abstract available. PMID: 9191538 [PubMed - indexed for MEDLINE]Related articlesFree article

Role of lipids in chronic renal allograft rejection.

Swan SK.

Contrib Nephrol. 1997;120:62-7. Review. No abstract available. PMID: 9257048 [PubMed - indexed for MEDLINE]Related articles

Aminoglycoside nephrotoxicity.

Swan SK.

Semin Nephrol. 1997 Jan;17(1):27-33. Review.PMID: 9000547 [PubMed - indexed for MEDLINE]Related articles

Dopamine does not enhance furosemide-induced natriuresis in patients with congestive heart failure.

Vargo DL, Brater DC, Rudy DW, Swan SK.

J Am Soc Nephrol. 1996 Jul;7(7):1032-7.PMID: 8829118 [PubMed - indexed for MEDLINE]Related articlesFree article

Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis.

Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F.

N Engl J Med. 1996 Apr 4;334(14):878-83.PMID: 8596570 [PubMed - indexed for MEDLINE]Related articlesFree article

Determination of residual renal function with iohexol clearance in hemodialysis patients.

Swan SK, Halstenson CE, Kasiske BL, Collins AJ.

Kidney Int. 1996 Jan;49(1):232-5.PMID: 8770973 [PubMed - indexed for MEDLINE]Related articles

Isoprenoids and Ras: potential role in chronic rejection.

O'Donnell MP, Kasiske BL, Massy ZA, Guijarro C, Swan SK, Keane WF.

Kidney Int Suppl. 1995 Dec;52:S29-33. Review.PMID: 8587279 [PubMed - indexed for MEDLINE]Related articles

Pharmacologic profile of diaspirin cross-linked hemoglobin in hemodialysis patients.

Swan SK, Halstenson CE, Collins AJ, Colburn WA, Blue J, Przybelski RJ.

Am J Kidney Dis. 1995 Dec;26(6):918-23.PMID: 7503066 [PubMed - indexed for MEDLINE]Related articles

Immunosuppressive effects of leflunomide in experimental chronic vascular rejection.

Swan SK, Crary GS, Guijarro C, O'Donnell MP, Keane WF, Kasiske BL.

Transplantation. 1995 Oct 27;60(8):887-90. No abstract available. PMID: 7482756 [PubMed - indexed for MEDLINE]Related articles

The angiotensin II receptor antagonist losartan reduces blood pressure but not renal injury in obese Zucker rats.

Crary GS, Swan SK, O'Donnell MP, Kasiske BL, Katz SA, Keane WF.

J Am Soc Nephrol. 1995 Oct;6(4):1295-9.PMID: 8589300 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat.

Gile RD, Cowley BD Jr, Gattone VH 2nd, O'Donnell MP, Swan SK, Grantham JJ.

Am J Kidney Dis. 1995 Sep;26(3):501-7.PMID: 7645559 [PubMed - indexed for MEDLINE]Related articles

Long-term effects of reduced renal mass in humans.

Kasiske BL, Ma JZ, Louis TA, Swan SK.

Kidney Int. 1995 Sep;48(3):814-9.PMID: 7474669 [PubMed - indexed for MEDLINE]Related articles

Diuretic strategies in patients with renal failure.

Swan SK.

Drugs. 1994 Sep;48(3):380-5. Review.PMID: 7527759 [PubMed - indexed for MEDLINE]Related articles

Pharmacologic limits of the protective effect of polyaspartic acid on experimental gentamicin nephrotoxicity.

Swan SK, Gilbert DN, Kohlhepp SJ, Kohnen PW, Bennett WM.

Antimicrob Agents Chemother. 1993 Feb;37(2):347-8.PMID: 8452369 [PubMed - indexed for MEDLINE]Related articlesFree article

On the probability that kidneys are different in autosomal dominant polycystic disease.

Gardner KD Jr, Burnside JS, Skipper BJ, Swan SK, Bennett WM, Connors BA, Evan AP.

Kidney Int. 1992 Nov;42(5):1199-206.PMID: 1453604 [PubMed - indexed for MEDLINE]Related articles

Duration of the protective effect of polyaspartic acid on experimental gentamicin nephrotoxicity.

Swan SK, Gilbert DN, Kohlhepp SJ, Leggett JE, Kohnen PW, Bennett WM.

Antimicrob Agents Chemother. 1992 Nov;36(11):2556-8.PMID: 1489205 [PubMed - indexed for MEDLINE]Related articlesFree article

Drug dosing guidelines in patients with renal failure.

Swan SK, Bennett WM.

West J Med. 1992 Jun;156(6):633-8.PMID: 1615656 [PubMed - indexed for MEDLINE]Related articlesFree article